These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 27004031)

  • 1. Mineral and bone disorders, morbidity and mortality in end-stage renal failure patients on chronic dialysis.
    Moldovan D; Rusu C; Kacso IM; Potra A; Patiu IM; Gherman-Caprioara M
    Clujul Med; 2016; 89(1):94-103. PubMed ID: 27004031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing Dialysis Modality and Cardiovascular Mortality in Patients on Hemodialysis and Peritoneal Dialysis.
    Refaat H; Sany D; Mohab A; Ezzat H
    Adv Perit Dial; 2016; 32():22-31. PubMed ID: 28988586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular calcifications and renal osteodystrophy in chronic hemodialysis patients: what is the relationship between them?
    Moldovan D; Moldovan I; Rusu C; Racasan S; Patiu IM; Brumboiu A; Bondor C; Parvu L; Kacso I; Orasan R; Gherman-Caprioara M
    Int Urol Nephrol; 2011 Dec; 43(4):1179-86. PubMed ID: 20862543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High alkaline phosphatase and low intact parathyroid hormone associate with worse clinical outcome in peritoneal dialysis patients.
    Chen Z; Zhang X; Han F; Xie X; Hua Z; Huang X; Lindholm B; Haarhaus M; Stenvinkel P; Qureshi AR; Chen J
    Perit Dial Int; 2021 Mar; 41(2):236-243. PubMed ID: 32363998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in Markers of Mineral and Bone Disorders and Mortality in Incident Hemodialysis Patients.
    Soohoo M; Feng M; Obi Y; Streja E; Rhee CM; Lau WL; Wang J; Ravel VA; Brunelli S; Kovesdy CP; Kalantar-Zadeh K
    Am J Nephrol; 2016; 43(2):85-96. PubMed ID: 26950688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infants Requiring Maintenance Dialysis: Outcomes of Hemodialysis and Peritoneal Dialysis.
    Vidal E; van Stralen KJ; Chesnaye NC; Bonthuis M; Holmberg C; Zurowska A; Trivelli A; Da Silva JEE; Herthelius M; Adams B; Bjerre A; Jankauskiene A; Miteva P; Emirova K; Bayazit AK; Mache CJ; Sánchez-Moreno A; Harambat J; Groothoff JW; Jager KJ; Schaefer F; Verrina E;
    Am J Kidney Dis; 2017 May; 69(5):617-625. PubMed ID: 27955924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dialysis outcomes in Colombia (DOC) study: a comparison of patient survival on peritoneal dialysis vs hemodialysis in Colombia.
    Sanabria M; Muñoz J; Trillos C; Hernández G; Latorre C; Díaz CS; Murad S; Rodríguez K; Rivera A; Amador A; Ardila F; Caicedo A; Camargo D; Díaz A; González J; Leguizamón H; Lopera P; Marín L; Nieto I; Vargas E
    Kidney Int Suppl; 2008 Apr; (108):S165-72. PubMed ID: 18379541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there impact of mortality prior hemodialysis therapy in peritoneal dialysis patients?
    Koc Y; Unsal A; Basturk T; Sakaci T; Ahbap-Dal E; Sinangil-Arar A; Kose-Budak S; Kayabasi H
    Nefrologia; 2012 May; 32(3):335-42. PubMed ID: 22508142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences.
    Jean G; Bresson E; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
    Nephrol Dial Transplant; 2009 Mar; 24(3):948-55. PubMed ID: 18852190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins for treatment of dyslipidemia in chronic kidney disease.
    Shurraw S; Tonelli M
    Perit Dial Int; 2006; 26(5):523-39. PubMed ID: 16973506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
    Jehle PM; Ostertag A; Schulten K; Schulz W; Jehle DR; Stracke S; Fiedler R; Deuber HJ; Keller F; Boehm BO; Baylink DJ; Mohan S
    Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early start of combination therapy with hemodialysis and peritoneal dialysis prolongs survival and reduces cardiovascular events in male patients.
    Suzuki H; Hoshi H; Inoue T; Kikuta T; Tsuda M; Takenaka T
    Adv Perit Dial; 2012; 28():68-73. PubMed ID: 23311217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low serum intact parathyroid hormone level is an independent risk factor for overall mortality and major adverse cardiac and cerebrovascular events in incident dialysis patients.
    Lee SA; Lee MJ; Ryu GW; Jhee JH; Kim HW; Park S; Jung SY; Oh HJ; Park JT; Han SH; Kang SW; Yoo TH
    Osteoporos Int; 2016 Sep; 27(9):2717-2726. PubMed ID: 27216997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes and mortality in peritoneal dialysis patients: a 10-year retrospective analysis in a single center.
    Unsal A; Koc Y; Basturk T; Sakaci T; Ahbap E; Sinangil A; Budak SK; Sevinc M; Kara E; Doner B
    Clin Nephrol; 2013 Oct; 80(4):270-9. PubMed ID: 23816475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients.
    Noordzij M; Korevaar JC; Bos WJ; Boeschoten EW; Dekker FW; Bossuyt PM; Krediet RT
    Nephrol Dial Transplant; 2006 Sep; 21(9):2513-20. PubMed ID: 16799173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparable outcome of acute unplanned peritoneal dialysis and haemodialysis.
    Koch M; Kohnle M; Trapp R; Haastert B; Rump LC; Aker S
    Nephrol Dial Transplant; 2012 Jan; 27(1):375-80. PubMed ID: 21622993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and risk factors for vascular calcification in Chinese patients receiving dialysis: baseline results from a prospective cohort study.
    Liu ZH; Yu XQ; Yang JW; Jiang AL; Liu BC; Xing CY; Lou JZ; Wang M; Cheng H; Liu J; Fu JZ; Zhang AH; Zhang M; Zhou QL; Yu C; Wang R; Wang L; Chen YQ; Guan TJ; Peng A; Chen N; Hao CM; Cheng XY;
    Curr Med Res Opin; 2018 Aug; 34(8):1491-1500. PubMed ID: 29672176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enrollment parathyroid hormone level is a new marker of survival in hemodialysis and peritoneal dialysis therapy for uremia.
    Avram MM; Sreedhara R; Avram DK; Muchnick RA; Fein P
    Am J Kidney Dis; 1996 Dec; 28(6):924-30. PubMed ID: 8957048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current peritoneal dialysis compared with haemodialysis: medium-term survival analysis of incident dialysis patients in the Canary Islands in recent years].
    Rufino JM; García C; Vega N; Macía M; Hernández D; Rodríguez A; Maceira B; Lorenzo V
    Nefrologia; 2011; 31(2):174-84. PubMed ID: 21461011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.